Impact of COVID-19 Outbreak on Felbamate, Global Market Research Report 2020

July 2020 | 91 pages | ID: I3D727EAF955EN
QYResearch

Abstracts

This report also analyses the impact of Coronavirus COVID-19 on the Felbamate industry.
Based on our recent survey, we have several different scenarios about the Felbamate YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Felbamate will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Felbamate market is segmented into

• Tablet
• Oral Solution

Segment by Application

• Refractory Lennox-Gastaut Syndrome
• Refractory Seizure Disorders
• Others

Global Felbamate Market: Regional Analysis
The Felbamate market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Felbamate market report are:

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• U.A.E

Global Felbamate Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Felbamate market include:

• Mylan
• Alvogen
• Amneal Pharmaceuticals
• Sun Pharma
• Cadila Healthcare
• Merck Sharp and Dohme
• Schering Plough
• Corepharma
• ANI Pharmaceuticals

Contents

1 FELBAMATE MARKET OVERVIEW

1.1 Product Overview and Scope of Felbamate
1.2 Covid-19 Implications on Felbamate Segment by Type
  1.2.1 Global Felbamate Sales Growth Rate Comparison by Type (2021-2026)
  1.2.2 Tablet
  1.2.3 Oral Solution
1.3 Covid-19 Implications on Felbamate Segment by Application
  1.3.1 Felbamate Sales Comparison by Application: 2020 VS 2026
  1.3.2 Refractory Lennox-Gastaut Syndrome
  1.3.3 Refractory Seizure Disorders
  1.3.4 Others
1.4 Covid-19 Implications on Global Felbamate Market Size Estimates and Forecasts
  1.4.1 Global Felbamate Revenue 2015-2026
  1.4.2 Global Felbamate Sales 2015-2026
  1.4.3 Felbamate Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Felbamate Industry Impact
  1.5.1 How the Covid-19 is Affecting the Felbamate Industry
    1.5.1.1 Felbamate Business Impact Assessment - Covid-19
    1.5.1.2 Supply Chain Challenges
    1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.5.2 Market Trends and Felbamate Potential Opportunities in the COVID-19 Landscape
  1.5.3 Measures / Proposal against Covid-19
    1.5.3.1 Government Measures to Combat Covid-19 Impact
    1.5.3.2 Proposal for Felbamate Players to Combat Covid-19 Impact

2 COVID-19 IMPLICATIONS ON GLOBAL FELBAMATE MARKET COMPETITION BY MANUFACTURERS

2.1 Global Felbamate Sales Market Share by Manufacturers (2015-2020)
2.2 Global Felbamate Revenue Share by Manufacturers (2015-2020)
2.3 Global Felbamate Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Felbamate Manufacturing Sites, Area Served, Product Type
2.5 Felbamate Market Competitive Situation and Trends
  2.5.1 Felbamate Market Concentration Rate
  2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Felbamate Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON FELBAMATE RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Felbamate Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Felbamate Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Felbamate Market Facts & Figures by Country
  3.3.1 North America Felbamate Sales by Country
  3.3.2 North America Felbamate Sales by Country
  3.3.3 U.S.
  3.3.4 Canada
3.4 Europe Felbamate Market Facts & Figures by Country
  3.4.1 Europe Felbamate Sales by Country
  3.4.2 Europe Felbamate Sales by Country
  3.4.3 Germany
  3.4.4 France
  3.4.5 U.K.
  3.4.6 Italy
  3.4.7 Russia
3.5 Asia Pacific Felbamate Market Facts & Figures by Region
  3.5.1 Asia Pacific Felbamate Sales by Region
  3.5.2 Asia Pacific Felbamate Sales by Region
  3.5.3 China
  3.5.4 Japan
  3.5.5 South Korea
  3.5.6 India
  3.5.7 Australia
  3.5.8 Taiwan
  3.5.9 Indonesia
  3.5.10 Thailand
  3.5.11 Malaysia
  3.5.12 Philippines
  3.5.13 Vietnam
3.6 Latin America Felbamate Market Facts & Figures by Country
  3.6.1 Latin America Felbamate Sales by Country
  3.6.2 Latin America Felbamate Sales by Country
  3.6.3 Mexico
  3.6.3 Brazil
  3.6.3 Argentina
3.7 Middle East and Africa Felbamate Market Facts & Figures by Country
  3.7.1 Middle East and Africa Felbamate Sales by Country
  3.7.2 Middle East and Africa Felbamate Sales by Country
  3.7.3 Turkey
  3.7.4 Saudi Arabia
  3.7.5 U.A.E

4 GLOBAL FELBAMATE HISTORIC MARKET ANALYSIS BY TYPE

4.1 Global Felbamate Sales Market Share by Type (2015-2020)
4.2 Global Felbamate Revenue Market Share by Type (2015-2020)
4.3 Global Felbamate Price Market Share by Type (2015-2020)
4.4 Global Felbamate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 GLOBAL FELBAMATE HISTORIC MARKET ANALYSIS BY APPLICATION

5.1 Global Felbamate Sales Market Share by Application (2015-2020)
5.2 Global Felbamate Revenue Market Share by Application (2015-2020)
5.3 Global Felbamate Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN FELBAMATE BUSINESS

6.1 Mylan
  6.1.1 Corporation Information
  6.1.2 Mylan Description, Business Overview and Total Revenue
  6.1.3 Mylan Felbamate Sales, Revenue and Gross Margin (2015-2020)
  6.1.4 Mylan Products Offered
  6.1.5 Mylan Recent Development
6.2 Alvogen
  6.2.1 Alvogen Corporation Information
  6.2.2 Alvogen Description, Business Overview and Total Revenue
  6.2.3 Alvogen Felbamate Sales, Revenue and Gross Margin (2015-2020)
  6.2.4 Alvogen Products Offered
  6.2.5 Alvogen Recent Development
6.3 Amneal Pharmaceuticals
  6.3.1 Amneal Pharmaceuticals Corporation Information
  6.3.2 Amneal Pharmaceuticals Description, Business Overview and Total Revenue
  6.3.3 Amneal Pharmaceuticals Felbamate Sales, Revenue and Gross Margin (2015-2020)
  6.3.4 Amneal Pharmaceuticals Products Offered
  6.3.5 Amneal Pharmaceuticals Recent Development
6.4 Sun Pharma
  6.4.1 Sun Pharma Corporation Information
  6.4.2 Sun Pharma Description, Business Overview and Total Revenue
  6.4.3 Sun Pharma Felbamate Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Sun Pharma Products Offered
  6.4.5 Sun Pharma Recent Development
6.5 Cadila Healthcare
  6.5.1 Cadila Healthcare Corporation Information
  6.5.2 Cadila Healthcare Description, Business Overview and Total Revenue
  6.5.3 Cadila Healthcare Felbamate Sales, Revenue and Gross Margin (2015-2020)
  6.5.4 Cadila Healthcare Products Offered
  6.5.5 Cadila Healthcare Recent Development
6.6 Merck Sharp and Dohme
  6.6.1 Merck Sharp and Dohme Corporation Information
  6.6.2 Merck Sharp and Dohme Description, Business Overview and Total Revenue
  6.6.3 Merck Sharp and Dohme Felbamate Sales, Revenue and Gross Margin (2015-2020)
  6.6.4 Merck Sharp and Dohme Products Offered
  6.6.5 Merck Sharp and Dohme Recent Development
6.7 Schering Plough
  6.6.1 Schering Plough Corporation Information
  6.6.2 Schering Plough Description, Business Overview and Total Revenue
  6.6.3 Schering Plough Felbamate Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Schering Plough Products Offered
  6.7.5 Schering Plough Recent Development
6.8 Corepharma
  6.8.1 Corepharma Corporation Information
  6.8.2 Corepharma Description, Business Overview and Total Revenue
  6.8.3 Corepharma Felbamate Sales, Revenue and Gross Margin (2015-2020)
  6.8.4 Corepharma Products Offered
  6.8.5 Corepharma Recent Development
6.9 ANI Pharmaceuticals
  6.9.1 ANI Pharmaceuticals Corporation Information
  6.9.2 ANI Pharmaceuticals Description, Business Overview and Total Revenue
  6.9.3 ANI Pharmaceuticals Felbamate Sales, Revenue and Gross Margin (2015-2020)
  6.9.4 ANI Pharmaceuticals Products Offered
  6.9.5 ANI Pharmaceuticals Recent Development

7 FELBAMATE MANUFACTURING COST ANALYSIS

7.1 Felbamate Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price Trend
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Felbamate
7.4 Felbamate Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

8.1 Marketing Channel
8.2 Felbamate Distributors List
8.3 Felbamate Customers

9 MARKET DYNAMICS

9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

10.1 Global Felbamate Market Estimates and Projections by Type
  10.1.1 Global Forecasted Sales of Felbamate by Type (2021-2026)
  10.1.2 Global Forecasted Revenue of Felbamate by Type (2021-2026)
10.2 Felbamate Market Estimates and Projections by Application
  10.2.1 Global Forecasted Sales of Felbamate by Application (2021-2026)
  10.2.2 Global Forecasted Revenue of Felbamate by Application (2021-2026)
10.3 Felbamate Market Estimates and Projections by Region
  10.3.1 Global Forecasted Sales of Felbamate by Region (2021-2026)
  10.3.2 Global Forecasted Revenue of Felbamate by Region (2021-2026)
10.4 North America Felbamate Estimates and Projections (2021-2026)
10.5 Europe Felbamate Estimates and Projections (2021-2026)
10.6 Asia Pacific Felbamate Estimates and Projections (2021-2026)
10.7 Latin America Felbamate Estimates and Projections (2021-2026)
10.8 Middle East and Africa Felbamate Estimates and Projections (2021-2026)

11 RESEARCH FINDING AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Felbamate Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Felbamate Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Felbamate Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Felbamate Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Felbamate Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Felbamate Players to Combat Covid-19 Impact
Table 9. Global Key Felbamate Manufacturers Covered in This Study
Table 10. Global Felbamate Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Felbamate Sales Share by Manufacturers (2015-2020)
Table 12. Global Felbamate Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Felbamate Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Felbamate Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Felbamate Sales Sites and Area Served
Table 16. Manufacturers Felbamate Product Types
Table 17. Global Felbamate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Felbamate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Felbamate as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Felbamate Players
Table 21. Global Felbamate Sales (K Units) by Region (2015-2020)
Table 22. Global Felbamate Sales Market Share by Region (2015-2020)
Table 23. Global Felbamate Revenue (Million US$) by Region (2015-2020)
Table 24. Global Felbamate Revenue Market Share by Region (2015-2020)
Table 25. North America Felbamate Sales by Country (2015-2020) (K Units)
Table 26. North America Felbamate Sales Market Share by Country (2015-2020)
Table 27. North America Felbamate Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Felbamate Revenue Market Share by Country (2015-2020)
Table 29. Europe Felbamate Sales by Country (2015-2020) (K Units)
Table 30. Europe Felbamate Sales Market Share by Country (2015-2020)
Table 31. Europe Felbamate Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Felbamate Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Felbamate Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Felbamate Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Felbamate Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Felbamate Revenue Market Share by Region (2015-2020)
Table 37. Latin America Felbamate Sales by Country (2015-2020) (K Units)
Table 38. Latin America Felbamate Sales Market Share by Country (2015-2020)
Table 39. Latin America Felbamate Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Felbamate Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Felbamate Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Felbamate Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Felbamate Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Felbamate Revenue Market Share by Country (2015-2020)
Table 45. Global Felbamate Sales (K Units) by Type (2015-2020)
Table 46. Global Felbamate Sales Share by Type (2015-2020)
Table 47. Global Felbamate Revenue (Million US$) by Type (2015-2020)
Table 48. Global Felbamate Revenue Share by Type (2015-2020)
Table 49. Global Felbamate Price (US$/Unit) by Type (2015-2020)
Table 50. Global Felbamate Sales (K Units) by Application (2015-2020)
Table 51. Global Felbamate Sales Market Share by Application (2015-2020)
Table 52. Global Felbamate Sales Growth Rate by Application (2015-2020)
Table 53. Mylan Felbamate Corporation Information
Table 54. Mylan Description and Business Overview
Table 55. Mylan Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Mylan Main Product
Table 57. Mylan Recent Development
Table 58. Alvogen Felbamate Corporation Information
Table 59. Alvogen Corporation Information
Table 60. Alvogen Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Alvogen Main Product
Table 62. Alvogen Recent Development
Table 63. Amneal Pharmaceuticals Felbamate Corporation Information
Table 64. Amneal Pharmaceuticals Corporation Information
Table 65. Amneal Pharmaceuticals Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Amneal Pharmaceuticals Main Product
Table 67. Amneal Pharmaceuticals Recent Development
Table 68. Sun Pharma Felbamate Corporation Information
Table 69. Sun Pharma Corporation Information
Table 70. Sun Pharma Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Sun Pharma Main Product
Table 72. Sun Pharma Recent Development
Table 73. Cadila Healthcare Felbamate Corporation Information
Table 74. Cadila Healthcare Corporation Information
Table 75. Cadila Healthcare Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Cadila Healthcare Main Product
Table 77. Cadila Healthcare Recent Development
Table 78. Merck Sharp and Dohme Felbamate Corporation Information
Table 79. Merck Sharp and Dohme Corporation Information
Table 80. Merck Sharp and Dohme Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Merck Sharp and Dohme Main Product
Table 82. Merck Sharp and Dohme Recent Development
Table 83. Schering Plough Felbamate Corporation Information
Table 84. Schering Plough Corporation Information
Table 85. Schering Plough Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Schering Plough Main Product
Table 87. Schering Plough Recent Development
Table 88. Corepharma Felbamate Corporation Information
Table 89. Corepharma Corporation Information
Table 90. Corepharma Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Corepharma Main Product
Table 92. Corepharma Recent Development
Table 93. ANI Pharmaceuticals Felbamate Corporation Information
Table 94. ANI Pharmaceuticals Corporation Information
Table 95. ANI Pharmaceuticals Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. ANI Pharmaceuticals Main Product
Table 97. ANI Pharmaceuticals Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Felbamate Distributors List
Table 101. Felbamate Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Felbamate Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global Felbamate Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Felbamate Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Felbamate Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Felbamate Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global Felbamate Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Felbamate Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global Felbamate Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Felbamate Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Felbamate Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Felbamate
Figure 2. Global Felbamate Sales Market Share by Type: 2020 VS 2026
Figure 3. Tablet Product Picture
Figure 4. Oral Solution Product Picture
Figure 5. Global Felbamate Consumption Market Share by Application: 2020 VS 2026
Figure 6. Refractory Lennox-Gastaut Syndrome
Figure 7. Refractory Seizure Disorders
Figure 8. Others
Figure 9. Global Felbamate Market Size 2015-2026 (US$ Million)
Figure 10. Global Felbamate Sales Capacity (K Units) (2015-2026)
Figure 11. Global Felbamate Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Felbamate Sales Share by Manufacturers in 2020
Figure 13. Global Felbamate Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Felbamate Revenue in 2019
Figure 15. Felbamate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Felbamate Sales Market Share by Region (2015-2020)
Figure 17. Global Felbamate Sales Market Share by Region in 2019
Figure 18. Global Felbamate Revenue Market Share by Region (2015-2020)
Figure 19. Global Felbamate Revenue Market Share by Region in 2019
Figure 20. North America Felbamate Sales Market Share by Country in 2019
Figure 21. North America Felbamate Revenue Market Share by Country in 2019
Figure 22. U.S. Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Felbamate Sales Market Share by Country in 2019
Figure 27. Europe Felbamate Revenue Market Share by Country in 2019
Figure 28. Germany Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Felbamate Sales Market Share by Region in 2019
Figure 39. Asia Pacific Felbamate Revenue Market Share by Region in 2019
Figure 40. China Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Felbamate Sales Market Share by Country in 2019
Figure 63. Latin America Felbamate Revenue Market Share by Country in 2019
Figure 64. Mexico Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Felbamate Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Felbamate Revenue Market Share by Country in 2019
Figure 72. Turkey Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Felbamate Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Felbamate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Felbamate by Type (2015-2020)
Figure 79. Sales Market Share of Felbamate by Type in 2019
Figure 80. Revenue Share of Felbamate by Type (2015-2020)
Figure 81. Revenue Market Share of Felbamate by Type in 2019
Figure 82. Global Felbamate Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Felbamate Sales Market Share by Application (2015-2020)
Figure 84. Global Felbamate Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Felbamate by Application (2015-2020)
Figure 86. Global Revenue Share of Felbamate by Application in 2020
Figure 87. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Alvogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Cadila Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Merck Sharp and Dohme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Schering Plough Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Corepharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. ANI Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of Felbamate
Figure 98. Manufacturing Process Analysis of Felbamate
Figure 99. Felbamate Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America Felbamate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. North America Felbamate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Felbamate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Felbamate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Felbamate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Felbamate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Felbamate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Felbamate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Felbamate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Felbamate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed